real world tandem asct for high risk mm
Published 4 years ago • 157 plays • Length 2:59Download video MP4
Download video MP3
Similar videos
-
0:59
tandem transplantation for patients with myeloma with high-risk cytogenetics
-
3:08
defining newly diagnosed high-risk mm
-
1:58
high-risk myeloma and muk nine
-
6:38
real-world efficacy & safety of teclistamab in patients with heavily pretreated r/r multiple myeloma
-
2:46
managing patients with high-risk myeloma
-
3:12
allogeneic hsct in patients with high-risk myeloma
-
3:51
bmt ctn 1302: maintenance ixazomib following allohct in patients with high-risk myeloma
-
4:24
monoclonal antibodies for myeloma relapsed after asct
-
2:37
tandem meetings myeloma highlights: pano/gembumel with autosct, karmma-3 & more
-
2:49
the importance of timing in autologous transplantation for multiple myeloma
-
2:43
collecting real world data from novel treatments
-
2:42
results from majestec-1: health-related quality of life with teclistamab in patients with r/r mm
-
5:18
upfront treatment in transplant candidates
-
54:44
the value of a patient-centric & real-time approach to real-world data in clinical trials
-
7:51
real-world data and its real-world use
-
4:46
what unique healthcare challenge is tausight looking to solve?
-
2:43
reuters: the real world in real time™